skip to main content

SLE Pregnancy Timing — SCE Rheumatology MCQ

Instant feedback + full explanation. One question, done properly.

EasySLE & Antiphospholipid SyndromeSLE Pregnancy TimingSCE Rheumatology

A 32-year-old woman with systemic lupus erythematosus wishes to conceive. She has no irreversible organ dysfunction that would contraindicate pregnancy. Which preconception disease-control target is most appropriate?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Clinical remission, or stable low disease activity if remission is not achievable, for at least 6 months on pregnancy-compatible treatment

The preferred target is clinical remission for at least 6 months before conception; stable low disease activity for the same period is an acceptable pragmatic target when remission cannot be achieved. Disease control should already be maintained with pregnancy-compatible medication. Active clinical SLE at conception, particularly active lupus nephritis, increases the risks of maternal flare and adverse obstetric outcomes. Normal renal function does not make moderate systemic activity acceptable, so B is incorrect. Serological improvement alone is insufficient when clinical disease remains active, excluding C. A mandatory 2-year remission period is unsupported and could unnecessarily delay pregnancy, excluding D. Specialist multidisciplinary care reduces risk but does not remove the need for preconception disease control, excluding E.

Reference: Balancing stringency and feasibility: comparative value of disease-activity measures to predict pregnancy outcomes in systemic lupus erythematosus. Lupus Science & Medicine 2026;13:e001793 (preconception remission/low disease activity for ≥6 months). https://pubmed.ncbi.nlm.nih.gov/40287311/